Wird geladen...
A Phase II Clinical Trial of Ixabepilone (Ixempra®, BMS-247550, NSC 710428), an Epothilone B Analog, in Patients with Metastatic Renal Cell Carcinoma
PURPOSE: Ixabepilone (Ixempra®; BMS-247550) is an epothilone B analog and non-taxane microtubule-stabilizing compound with clinical activity in a range of solid tumors. This phase II study was conducted to assess the efficacy and safety of ixabepilone in patients with metastatic renal cell carcinoma...
Gespeichert in:
| Veröffentlicht in: | Clin Cancer Res |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7006234/ https://ncbi.nlm.nih.gov/pubmed/20179242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0379 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|